Transl Clin Pharmacol.  2020 Mar;28(1):1-6. 10.12793/tcp.2020.28.e1.

What is the optimal fit-for-purpose design in an oncology first-in-human trial?: 3+3 vs. Bayesian Logistic Regression Model

Affiliations
  • 1Brain Boutique, Inc., Seoul, Korea

Full Text Links
  • TCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr